New improved radiometabolite analysis method for [18F]FTHA from human plasma : a test-retest study with postprandial and fasting state

dc.contributor.authorAarnio, Richard
dc.contributor.authorKirjavainen, Anna
dc.contributor.authorRajander, Johan
dc.contributor.authorForsback, Sarita
dc.contributor.authorKalliokoski, Kari
dc.contributor.authorNuutila, Pirjo
dc.contributor.authorMilicevic, Zvonko
dc.contributor.authorCoskun, Tamer
dc.contributor.authorHaupt, Axel
dc.contributor.authorLaitinen, Iina
dc.contributor.authorHaaparanta-Solin, Merja
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=MediCity|en=MediCity|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id456997216
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/456997216
dc.date.accessioned2025-08-27T22:33:25Z
dc.date.available2025-08-27T22:33:25Z
dc.description.abstract<p><strong>Background</strong><br>Fatty acid uptake can be measured using PET and 14-(<em>R</em>,<em>S</em>)‐[<sup>18</sup>F]fluoro‐6‐thia‐heptadecanoic acid ([<sup>18</sup>F]FTHA). However, the relatively rapid rate of [<sup>18</sup>F]FTHA metabolism significantly affects kinetic modeling of tissue uptake. Thus, there is a need for accurate chromatographic methods to analyze the unmetabolized [<sup>18</sup>F]FTHA (parent fraction). Here we present a new radiometabolite analysis (RMA) method, with comparison to a previous method for parent fraction analysis, and its use in a test-retest clinical study under fasting and postprandial conditions. We developed a new thin-layer chromatography (TLC) RMA method for analysis of [<sup>18</sup>F]FTHA parent fraction and its radiometabolites from plasma, by testing stationary phases and eluent combinations. Next, we analyzed [<sup>18</sup>F]FTHA, its radiometabolites, and plasma radioactivity from subjects participating in a clinical study. A total of 17 obese or overweight participants were dosed with [<sup>18</sup>F]FTHA twice under fasting, and twice under postprandial conditions and plasma samples were obtained between 14 min (mean of first sample) and 72 min (mean of last sample) post-injection. Aliquots of 70 plasma samples were analyzed using both methods, enabling head-to-head comparisons. We performed test-retest and group comparisons of the parent fraction and plasma radioactivity.<br></p><p><strong>Results</strong><br>The new TLC method separated seven [<sup>18</sup>F]FTHA radiometabolite peaks, while the previous method separated three. The new method revealed at least one radiometabolite that was not previously separable from [<sup>18</sup>F]FTHA. From the plasma samples, the mean parent fraction value was on average 7.2 percentage points lower with the new method, compared to the previous method. Repeated [<sup>18</sup>F]FTHA investigations on the same subject revealed reproducible plasma SUV and parent fractions, with different kinetics between the fasted and postprandial conditions.<br></p><p><strong>Conclusions</strong><br>The newly developed improved radio-TLC method for [<sup>18</sup>F]FTHA RMA enables accurate parent fraction correction, which is required to obtain quantitative data for modelling [<sup>18</sup>F]FTHA PET data. Our test-retest study of fasted and postprandial conditions showed robust reproducibility, and revealed clear differences in the [<sup>18</sup>F]FTHA metabolic rate under different study settings.<br></p><p><strong>Trial registration</strong><br>EudraCT No: 2020-005211-48, 04Feb2021; and Clinical Trials registry NCT05132335, 29Oct2021, URL: https://classic.clinicaltrials.gov/ct2/show/NCT05132335.<br></p>
dc.identifier.eissn2191-219X
dc.identifier.jour-issn2191-219X
dc.identifier.olddbid202369
dc.identifier.oldhandle10024/185396
dc.identifier.urihttps://www.utupub.fi/handle/11111/46843
dc.identifier.urnURN:NBN:fi-fe2025082789769
dc.language.isoen
dc.okm.affiliatedauthorAarnio, Richard
dc.okm.affiliatedauthorKirjavainen, Anna
dc.okm.affiliatedauthorForsback, Sarita
dc.okm.affiliatedauthorKalliokoski, Kari
dc.okm.affiliatedauthorNuutila, Pirjo
dc.okm.affiliatedauthorHaaparanta-Solin, Merja
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorDataimport, MediCity
dc.okm.discipline217 Medical engineeringen_GB
dc.okm.discipline217 Lääketieteen tekniikkafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSpringer Nature
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.relation.articlenumber53
dc.relation.doi10.1186/s13550-024-01114-5
dc.relation.ispartofjournalEJNMMI Research
dc.relation.issue1
dc.relation.volume14
dc.source.identifierhttps://www.utupub.fi/handle/10024/185396
dc.titleNew improved radiometabolite analysis method for [18F]FTHA from human plasma : a test-retest study with postprandial and fasting state
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s13550-024-01114-5.pdf
Size:
1.69 MB
Format:
Adobe Portable Document Format